Sebela Pharmaceuticals Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$11.8M
Doctors Paid
3,187
Transactions
7,750
2024 Total
$17.70
Payment Breakdown by Category
Research$11.2M (94.3%)
Consulting$551,979 (4.7%)
Food & Beverage$104,889 (0.9%)
Travel$15,479 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11.2M | 1,382 | 94.3% |
| Consulting Fee | $551,979 | 113 | 4.7% |
| Food and Beverage | $104,889 | 6,231 | 0.9% |
| Travel and Lodging | $15,479 | 23 | 0.1% |
| Grant | $500.00 | 1 | 0.0% |
Payments by Type
Research
$11.2M
1,382 transactions
General
$672,847
6,368 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability | $6.6M | 2 | 425 |
| A PHASE 3, PROSPECTIVE, MULTI-CENTER, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE VERACEPT, A LONG-ACTING REVERSIBLE INTRAUTERINE CONTRACEPTIVE FOR CONTRACEPTIVE EFFICACY, SAFETY, AND TOLERABILITY | $2.9M | 2 | 511 |
| SEB-ECP-202 | $448,938 | 0 | 28 |
| Evaluation of the Effectiveness, Safety and Tolerability of LevoCept Levonorgestrel-Releasing Intrauterine System for Long-Acting Reversible Contraception | $434,108 | 0 | 185 |
| EVALUATION OF THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF LEVOCEPT (LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM) FOR LONG-ACTING REVERSIBLE CONTRACEPTION | $286,494 | 0 | 132 |
| A Randomized, Single-Blind, Comparative Bioavailability Study to Assess the Pharmacokinetic Properties of VeraCept Intrauterine Contraceptive vs ParaGard in Healthy, Post-Menarcheal Women | $263,224 | 0 | 21 |
| Evaluation of the Effectiveness, Feasibility, Safety and Tolerability of the ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception | $167,673 | 0 | 49 |
| EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF LEVOCEPT | $32,560 | 0 | 10 |
| A RANDOMIZED, SINGLE-BLIND, COMPARATIVE BIOAVAILABILITY STUDY TO ASSESS THE PHARMACOKINETIC PROPERTIES OF VERACEPT INTRAUTERINE CONTRACEPTIVE VS PARAGARD IN HEALTHY, POST-MENARCHEAL WOMEN | $30,595 | 0 | 21 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Dr. Rex Mabey, M.d, M.D | Obstetrics & Gynecology | Las Vegas, NV | $491,938 | $0 |
| Arthur Waldbaum, Md, MD | Gynecology | Denver, CO | $346,293 | $0 |
| Dr. David Turok, M.d, M.D | Obstetrics & Gynecology | Salt Lake City, UT | $159,609 | $0 |
| Corey Siegel, M.d, M.D | Gastroenterology | Lebanon, NH | $77,000 | $0 |
| Ms. Phyllis Cason, Rn, Ms, Fnp-C, RN, MS, FNP-C | Family | Los Angeles, CA | $63,900 | $0 |
| Joshua Raphael Korzenik, M.d, M.D | Gastroenterology | Boston, MA | $57,600 | $0 |
| Michael Policar, Md Mph, MD MPH | Obstetrics & Gynecology | San Francisco, CA | $39,900 | $0 |
| Dr. Justin Diedrich, Md, MD | Gynecology | Agoura Hills, CA | $36,929 | $0 |
| David Portman, Md, MD | Obstetrics & Gynecology | Columbus, OH | $17,250 | $0 |
| Dr. Francis Farraye, M.d, M.D | Internal Medicine | Jacksonville, FL | $16,513 | $0 |
| Dr. Patricia Walker, M.d. Ph.d, M.D. PH.D | Dermatology | Carpinteria, CA | $15,500 | $0 |
| Dr. Matthew Reeves, Md, MD | Specialist | Chevy Chase, MD | $12,000 | $0 |
| Dr. Brooks Cash, Md, MD | Gastroenterology | Houston, TX | $9,400 | $0 |
| Dr. James Simon, M.d, M.D | Reproductive Endocrinology | Washington, DC | $9,000 | $0 |
| Luca Stocchi, Md, MD | Colon & Rectal Surgery | Jacksonville, FL | $6,000 | $0 |
| Dr. Miguel Regueiro, Md, MD | Specialist | Pittsburgh, PA | $5,625 | $0 |
| Dr. Anthony Lembo, M.d, M.D | Gastroenterology | Boston, MA | $4,050 | $0 |
| Colleen Kelly, Md, MD | Internal Medicine | Boston, MA | $3,900 | $0 |
| Dr. Yousif Arahim, M.d, M.D | Gastroenterology | Aiea, HI | $3,321 | $0 |
| Dr. Andrew Kaunitz, M.d, M.D | Obstetrics & Gynecology | Jacksonville, FL | $3,000 | $0 |
| James Liu, Md, MD | Reproductive Endocrinology | Cleveland, OH | $3,000 | $0 |
| Carol Burke, M.d, M.D | Gastroenterology | Cleveland, OH | $2,650 | $0 |
| Parveen Vahora, Md, MD | Specialist | New Port Richey, FL | $2,537 | $0 |
| Klaus Mergener, M.d, M.D | Gastroenterology | Edmonds, WA | $1,925 | $0 |
| Dawn Francis, Md, MD | Gastroenterology | Jacksonville, FL | $1,735 | $0 |
About Sebela Pharmaceuticals Inc.
Sebela Pharmaceuticals Inc. has made $11.8M in payments to 3,187 healthcare providers, recorded across 7,750 transactions in the CMS Open Payments database. In 2024, the company paid $17.70. The top product by payment volume is NAFTIN ($71,054).
Payments were distributed across 78 medical specialties. The top specialty by payment amount is Obstetrics & Gynecology ($717,074 to 264 doctors).
Payment categories include: Food & Beverage ($104,889), Consulting ($551,979), Research ($11.2M), Travel & Lodging ($15,479).
Sebela Pharmaceuticals Inc. is associated with 3 products in the CMS Open Payments database.